Glucagon-like peptide-1receptor agonists (GLP-1 RAs), such as semaglutide (Ozempic), are medications originally developed to treat type 2 diabetes.
Read more
NEDC e-BulletinContents: Editor’s Note AIS-NEDC launch Q&A interview with Shane Jeffrey Video interview with Fiona Sutherland Update on events Editor’s Note:Welcome to the NEDC e-Bulletin: Sport and Eating Disorders.
Read more
Eating Disorders: The Way Forward - A Strategic Communication Framework is a necessary compendium document to the Eating Disorders: The Way Forward, An Australian National Framework.
Read more
Editor’s Note Introduction of new NEDC body image fact sheet Associate Professor Rachel F.
Read more
